Top news of the week: 11.02.2021.
Companies And Industries
SEC Slaps Biotech Consultant Mark Ahn with Insider Trading Charges
A Portland, Oregon biotech consultant is facing two counts of insider trading charges, with federal prosecutors and securities regulators claiming the defendant made profitable stock trades ...
Avrobio gene therapy eliminates toxic substrate in Fabry patient
The first Fabry disease patient treated with Avrobio’s plato gene therapy platform in a phase 2 trial has experienced the complete clearance of toxic kidney substrate.
2021 Biopharma Update on the Novel Coronavirus: February 9
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 9, 2021.
Cheering biotech breakthroughs, from vaccines to Super Bowl snacks | BIO
Super Bowl Sunday is upon us—but today, we’re cheering for biotechnology breakthroughs that are ensuring the resiliency of our food supply and changing the course of the pandemic (plus a ...
Lucky seven: Biotech IPOs set a single-day record
The week finished with flurry of biotech IPOs, seven of them, a record number in a single day, according to BioWorld stats. Last year was a record year for IPOs as 106 new offerings were ...
J&J Sends One-Shot Vaccine to FDA, Emergency Use Authorization Expected End of February
Johnson & Johnson’s Janssen Biotech submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) for its single-dose COVID-19 vaccine.
Hebrew U. research replaces biopsies with simple blood tests
The test relies on a natural process.
Gilead's Kite unit snags ex-bluebird cancer research head after a stopover at Verastem
After a quick pit stop at Verastem Oncology, Frank Neumann, M.D., Ph.D. has landed at Gilead’s Kite Pharma, where he will lead clinical development in blood cancers and solid tumors. His ...